Episode 91 - EAACI 2024
Professor Marcus Maurer and Professor Martin Metz reflect on the European Academy of Allergy and Clinical Immunology (EAACI) congress 2024, including novel treatments on the horizon, key takeaways and expectations for future meetings. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here. Additional resources for this episode: Remibrutinib demonstrates favourable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks; andEuropean Medicines Agency approved indications for omalizumab biosimilar. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes! For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry. Episode  100 will be held live on UDAY (1 October 2024, 14:30 CEST). Submit your questions in advance to info@ga2len-ucare.com. Follow UCARE on Instagram to be notified of more information https://www.instagram.com/ga2len_acare_ucare/.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(123)

Urticaria as a Systemic Disease

Urticaria as a Systemic Disease

In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chroni...

25 Elo 22min

Disease Modification in Urticaria

Disease Modification in Urticaria

In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka fro...

21 Heinä 16min

AI and the Future of Urticaria

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Kesä 16min

Urticaria Triggers: Infection Insights

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Touko 16min

A New Era in Urticaria Treatment

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Huhti 19min

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Maalis 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Helmi 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Tammi 19min

Suosittua kategoriassa Tiede

utelias-mieli
rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-duodecim-lehti
rss-poliisin-mieli
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
mielipaivakirja
rss-hereilla
filocast-filosofian-perusteet
rss-miljonaarien-tasavalta
docemilia
rss-lihavuudesta-podcast
rss-sosiopodi
rss-politiikasta-podcast